Press Releases :: CohBar, Inc. (CWBR)

CohBar, Inc. and Morphogenesis, Inc. Enter into Definitive Merger Agreement to Advance an Innovative Late-stage Clinical Immuno-oncology Pipeline of Therapies to Overcome Resistance to Cancer Immunotherapy

The companies hosted a joint webcast on May 23, 2023, to discuss the transaction.

Morphogenesis Website

Access Webcast Replay

Jul 27, 2017 9:00am EDT

CohBar, Inc. to Announce Second Quarter 2017 Financial Results and Host Conference Call for Shareholders on August 14, 2017

Jul 17, 2017 9:00am EDT

CohBar, Inc. Completes US$5.2 Million Private Placement

Jun 23, 2017 9:00am EDT

CohBar, Inc. Announces Private Placement Offering

Jun 01, 2017 4:15pm EDT

CohBar, Inc. to Hold 2017 Annual Shareholder Meeting and Investor Update June 15, 2017

May 15, 2017 9:00am EDT

CohBar, Inc. Announces First Quarter 2017 Financial Results

Mar 29, 2017 5:33pm EDT

CohBar, Inc.’s CEO Simon Allen to Present at the 1st Annual H.C. Wainwright & Co. NASH Investor Conference in New York

Mar 22, 2017 4:05pm EDT

CohBar, Inc. Announces Fourth Quarter 2016 Financial Results

Mar 03, 2017 11:00am EST

CohBar, Inc. to Announce Fourth Quarter 2016 Financial Results and Host Conference Call for Shareholders on March 22, 2017

Feb 21, 2017 8:30am EST

CohBar, Inc. Announces Positive Results from Preclinical NASH Study of its Lead Drug Candidates

Feb 09, 2017 8:30am EST

CohBar, Inc.’s CEO Simon Allen to Present at the 2017 BIO CEO & Investor Conference in New York